Business
Nuvectis Pharma, Inc. to Present at Upcoming Investment Conferences
FORT LEE, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. ("Nuvectis", "Company"), a biopharmaceutical company focused on the development of
About this update from Nuvectis Pharma, Inc.
[{"type":"text","content":"FORT LEE, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (\"Nuvectis\", \"Company\"), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis, will present at the following investor conferences in September. EventHC Wainwright 24th Annual Global Investment ConferenceDateSeptember 13, 2022Time10:30 a.m. ETLocationNew YorkWebcast link ahttps://journey.ct.events/view/638cef0e-8c84-4cdf-85b0-befd7c815019 A live webcast of the presentation will be available on the link provided for approximately 90 days. EventCantor Oncology, Hematology & HemeOnc ConferenceDateSeptember 28, 2022Time9:00 am ETLocationNew YorkEventLadenburg Thalmann 2022 Healthcare ConferenceDateSeptember 29, 2022Time2:00 pm ETLocationNew YorkWebcast link ahttps://wsw.com/webcast/ladenburg8/nvct/2441476 A live webcast of the presentation will be available on the link provided for approximately 90 days. About Nuvectis Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. The Company's pipeline includes NXP800, an HSF1-pathway inhibitor, in Phase 1 studies in the EU and U.S., and NXP900, a SRC/YES1 kinase inhibitor in IND-enabling studies. For more information, please visit www.nuvectis.com. Forward Looking Statements This press release contains \"forward-looking statements\" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as \"anticipate,\" \"believe,\" \"contemplate,\" \"could,\" \"estimate,\" \"expect,\" \"intend,\" \"seek,\" \"may,\" \"might,\" \"plan,\" \"potential,\" \"predict,\" \"project,\" \"target,\" \"aim,\" \"should,\" \"will,\" \"would,\" or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Nuvectis Pharma, Inc.'s curren...